Yu-Bao Zheng
Overview
Explore the profile of Yu-Bao Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
376
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang X, Li X, Wu B, Yang Q, Zheng Y, Zheng M, et al.
J Infect Dis
. 2025 Feb;
PMID: 39960318
Background: Individuals who do not match any specific stage in the natural history of chronic hepatitis B are classified into the grey-zone, and appropriate management for these patients remains unclear....
2.
Zhang Y, Luo S, Li H, Sun S, Wang X, Zheng X, et al.
World J Hepatol
. 2024 May;
16(5):809-821.
PMID: 38818287
Background: Acute-on-chronic liver disease (AoCLD) accounts for the majority of patients hospitalized in the Department of Hepatology or Infectious Diseases. Aim: To explore the characterization of AoCLD to provide theoretical...
3.
Yu S, Li H, Deng G, Wang X, Zheng X, Chen J, et al.
World J Gastroenterol
. 2024 Apr;
30(9):1177-1188.
PMID: 38577193
Background: Acute decompensation (AD) of cirrhosis is associated with high short-term mortality, mainly due to the development of acute-on-chronic liver failure (ACLF). Thus, there is a need for biomarkers for...
4.
Hu Y, Pan T, Cai X, He Q, Zheng Y, Huang M, et al.
J Gastrointest Oncol
. 2023 Sep;
14(4):1837-1848.
PMID: 37720446
Background: Transarterial chemoembolization (TACE) is the standard treatment for hepatocellular carcinoma (HCC); the value of its combination with systemic therapy is worthy of further exploration. This study aimed to investigate...
5.
Shen Z, Wu D, Xia J, Wang X, Zheng X, Huang Y, et al.
World J Gastroenterol
. 2022 Sep;
28(31):4417-4430.
PMID: 36159019
Background: Autoimmune liver disease (AILD) has been considered a relatively uncommon disease in China, epidemiological data for AILD in patients with cirrhosis and acute decompensation (AD) is sparse. Aim: To...
6.
Chen J, Chen S, Lei Z, Cao H, Zhang S, Weng W, et al.
Hepatol Int
. 2022 May;
16(4):775-788.
PMID: 35616850
Background/purpose Of The Study: Mortality from hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF) is high. Severe infection is the most important complication that affects the outcomes of ACLF patients....
7.
Wu Z, Zheng Y, Wang K, Mo Z, Zhen X, Yan Y, et al.
Can J Gastroenterol Hepatol
. 2021 Nov;
2021:5545181.
PMID: 34805027
Objective: To identify markers that predict the progression to hepatitis B virus-associated acute-on-chronic liver failure (HBV-ACLF). Methods: We recruited 125 patients with chronic hepatitis B (CHB) between September 2013 and...
8.
Zhang Y, Cao J, Chen X, Chen J, Zheng Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
. 2021 Jul;
43(3):371-381.
PMID: 34238413
Objective To explore the function and mechanism of related genes in the occurrence and development of liver cancer, and the possibility of key genes as potential biomarkers and prognostic indicators...
9.
Jin J, Zheng Y, Zheng J, Liu J, Mao Y, Chen S, et al.
Eur Radiol
. 2018 Apr;
28(10):4465-4474.
PMID: 29696433
Objectives: To evaluate accuracy of two-dimensional shear wave elastography (2D SWE) and develop and validate a new prognostic score in predicting prognosis of acute-on-chronic liver failure (ACLF) patients. Methods: From...
10.
Zhu H, Gu Y, Zhang G, Su Y, Wang K, Zheng Y, et al.
Exp Ther Med
. 2016 Jun;
12(1):405-409.
PMID: 27347069
Depression in patients with chronic hepatitis B (CHB) can affect the quality of life, disease diagnosis and case fatality rate. The aim of this study was to explore depression in...